The headline may have changed at CNBC, but it now more accurately says "FDA <i>panel</i> recommends approval of Pfizer’s Covid vaccine for emergency use" (emphasis mine). The next, and final step, will likely happen pretty quickly:<p>> Following the advisory committee meeting, FDA’s career professional staff will consider the input of the advisory committee members and continue their evaluation of the submission to determine whether the available safety and effectiveness and manufacturing data support an emergency use authorization of the specific COVID-19 vaccine in the United States.<p><a href="https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained" rel="nofollow">https://www.fda.gov/vaccines-blood-biologics/vaccines/emerge...</a>